TCIM
ANTH
TIAA CREF Investment Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-126,380
| Closed | -$54K | – | 3221 |
|
|
2017
Q1 | $54K | Hold |
126,380
| – | – | ﹤0.01% | 3060 |
|
|
2016
Q4 | $82K | Sell |
126,380
-5,350
| -4% | -$3.47K | ﹤0.01% | 3093 |
|
|
2016
Q3 | $415 | Sell |
131,730
-80,727
| -38% | -$254 | ﹤0.01% | 2924 |
|
|
2016
Q2 | $656K | Buy |
212,457
+3,747
| +2% | +$11.6K | ﹤0.01% | 2750 |
|
|
2016
Q1 | $756K | Sell |
208,710
-1,890
| -0.9% | -$6.85K | ﹤0.01% | 2619 |
|
|
2015
Q4 | $977K | Hold |
210,600
| – | – | ﹤0.01% | 2597 |
|
|
2015
Q3 | $1.28M | Buy |
210,600
+23,282
| +12% | +$142K | ﹤0.01% | 2419 |
|
|
2015
Q2 | $1.62M | Buy |
+187,318
| New | +$1.62M | ﹤0.01% | 2431 |
|